effect of add on therapy of dipeptidyl peptidase 4 inhibitors and sodium glucose cotransporter 2 inhibitors on visceral fat associated adipokines in inadequately controlled central obese type 2 diabetic patients on metformin monotherapy

dc.contributor.guide	Ashok Kumar P
dc.coverage.spatial
dc.creator.researcher	Abid Shaheer Karanghadan
dc.date.accessioned	2022-08-26T04:25:55Z
dc.date.available	2022-08-26T04:25:55Z
dc.date.awarded	2022
dc.date.completed	2022
dc.date.registered	2016
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent
dc.identifier.uri	http://hdl.handle.net/10603/401476
dc.language	English
dc.publisher.institution	Department of Bio-Chemistry
dc.publisher.place	Annamalai Nagar
dc.publisher.university	Annamalai University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Life Sciences
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Biochemistry and Molecular Biology
dc.title	effect of add on therapy of dipeptidyl peptidase 4 inhibitors and sodium glucose cotransporter 2 inhibitors on visceral fat associated adipokines in inadequately controlled central obese type 2 diabetic patients on metformin monotherapy
dc.title.alternative
dc.type.degree	Ph.D.